Paul Jorgensen
Senior Associate
Norton Rose Fulbright Canada LLP
Related services and key industries
Related services
Biography
Paul Jorgensen is an intellectual property and life sciences lawyer, with extensive experience in pharmaceutical and biotechnology patent litigation.
Dr. Jorgensen has been involved in many complex patent proceedings, including multiple trials before the Federal Court, actions under the Patented Medicines (Notice of Compliance) Regulations, damages actions, and appeals. He also provides strategic advice on patent infringement and validity. Dr. Jorgensen brings deep scientific understanding to his patent matters. Before becoming a lawyer, Dr. Jorgensen was a scientist at Harvard Medical School and the University of Toronto, where he researched the molecular basis of cancers. He is an author on over 20 scientific publications.
Dr. Jorgensen's practice includes trademarks disputes, product liability litigation, and pro bono work with a focus on housing rights. He is also an editor of the firm's Pharma in Brief bulletin.
Before joining the firm, Dr. Jorgensen articled at a leading intellectual property boutique firm and clerked at the Court of Appeal for Ontario.
Professional experience
Collapse allJ.D., Osgoode Hall Law School, 2013
Ph.D., University of Toronto, 2004
B.Sc., University of British Columbia, 1998
- Ontario 2014
- Best Lawyers in Canada: Biotechnology and Life Sciences Practice, 2025
- Best Lawyers: Ones to Watch in Canada: Intellectual Property Law, 2024
- The Advocates' Society
- Intellectual Property Institute of Canada, Litigation Committee
- Canadian Bar Association
- Pro bono work, Canadian Centre for Housing Rights and Pro Bono Ontario
Insights
Gene therapy products in Canada
Publication | June 6, 2024
Canada’s new patent term adjustment system: CIPO sets the terms
Publication | May 24, 2024
Bill C-47: Canada announces patent term adjustment (PTA) legislation
Publication | May 5, 2023
Client work
Pfizer seeks to invalidate a Canadian patent
October 17, 2022